Singhe Hospitals 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Amarakone Weerasinghe

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	86.4%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	6.5yrs

최근 관리 업데이트

Recent updates

CEO

Amarakone Weerasinghe

no data

테뉴어

Mr. Amarakone Mudiyanselage Weerasinghe serves as the Chairman, Chief Executive Officer and Executive Director of Singhe Hospitals Plc (Singhe Hospitals Pvt Ltd). Mr. Weerasinghe serves as the Chairman of...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Amarakone Weerasinghe	Chairman & CEO	no data	데이터 없음	86.41% LKR 931.7m
Amarakoon Lakshika Weerasinghe	Marketing Director & Executive Director	no data	데이터 없음	데이터 없음
Amarakoon M. D. H. Weerasinghe	MD & Executive Director	no data	데이터 없음	0% LKR 0
Aznayn Mohiadeen Cader	Independent Non-Executive Director	9.3yrs	데이터 없음	데이터 없음
H. M. A. Weerasekara	Senior Independent Director	9.5yrs	데이터 없음	데이터 없음
Aruna Jayakody	Independent Non Executive Director	less than a year	데이터 없음	데이터 없음
Amarakoon Mudiyanselage Navanjana Weerasinghe	Non-Executive-Non Independent Director	3.7yrs	데이터 없음	데이터 없음
Uggal Bawula Hewagamage Kithsiri	Independent Non-Executive Director	13.6yrs	데이터 없음	0.26% LKR 2.7m
Chaaminda Kumarasiri	Non-Executive Independent Director	less than a year	데이터 없음	데이터 없음

6.5yrs

평균 재임 기간

경험이 풍부한 이사회: SINH.N0000 의 이사회는 경험(평균 재직 기간 6.5 년)으로 간주됩니다.

Singhe Hospitals 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Singhe Hospitals PLC, Annual General Meeting, Aug 22, 2024

Insufficient new directors

Independent Non-Executive Director recently bought LK₨2.3m worth of stock

Independent Non-Executive Director recently sold LK₨124k worth of stock

Chairman & CEO recently sold LK₨433k worth of stock

Recent updates

Second quarter 2025 earnings released: EPS: LK₨0.04 (vs LK₨0.03 loss in 2Q 2024)

First quarter 2025 earnings released: EPS: LK₨0.02 (vs LK₨0.05 loss in 1Q 2024)

Singhe Hospitals PLC, Annual General Meeting, Aug 22, 2024

New major risk - Share price stability

Full year 2024 earnings released: EPS: LK₨0 (vs LK₨0.024 in FY 2023)

New minor risk - Share price stability

Insufficient new directors

Third quarter 2024 earnings released: EPS: LK₨0.03 (vs LK₨0.04 in 3Q 2023)

New major risk - Share price stability

First quarter 2024 earnings released: LK₨0.05 loss per share (vs LK₨0.01 loss in 1Q 2023)

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: LK₨0.024 (vs LK₨0.038 in FY 2022)

Full year 2023 earnings released: EPS: LK₨0.03 (vs LK₨0.038 in FY 2022)

Third quarter 2023 earnings released: EPS: LK₨0.04 (vs LK₨0.005 in 3Q 2022)

First quarter 2023 earnings released: LK₨0.01 loss per share (vs LK₨0 in 1Q 2022)

Full year 2022 earnings released: EPS: LK₨0.04 (vs LK₨0.005 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS LK₨0.02 (vs LK₨0.01 in 2Q 2021)

Independent Non-Executive Director recently bought LK₨2.3m worth of stock

Third quarter 2021 earnings released: LK₨0.01 loss per share (vs LK₨0.029 profit in 3Q 2020)

New 90-day low: LK₨2.50

Independent Non-Executive Director recently sold LK₨124k worth of stock

Chairman & CEO recently sold LK₨433k worth of stock

New 90-day high: LK₨3.00

New 90-day high: LK₨2.10

New 90-day high - LK₨1.80

CEO

테뉴어

이사회 구성원

평균 재임 기간